QR Code

Fulvestrant in hormone-positive advanced breast cancer: Real-world outcome

Background: Fulvestrant has been shown to improve survival in hormone-positive, HER2-negative advanced breast cancer (ABC). There is no study on fulvestrant from India. Objectives: This study was done to assess the prognostic factors and outcome of patients with ABC treated with fulvestrant. Materia...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Indhuja Muthiah Vaikundaraja, Manikandan Dhanushkodi, Venkatraman Radhakrishnan, Jayachandran Perumal Kalaiarasi, Nikita Mehra, Arun Kumar Rajan, Gangothri Selvarajan, Siva Sree Kesana, Balasubramanian Ananthi, Priya Iyer, Geetha Senguttuvan, Manjula Rao, Arvind Krishnamurthy, Sridevi Velusamy, Hemanth Raj, Rama Ranganathan, Shirley Sundersingh, Selvaluxmy Ganesarajah, Trivadi S Ganesan, Tenali Gnana Sagar
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Wolters Kluwer Medknow Publications 2020-01-01
Rangatū:Cancer Research, Statistics, and Treatment
Ngā marau:
advanced breast cancer
fulvestrant
hormone positive
Urunga tuihono:http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=2;spage=275;epage=280;aulast=Vaikundaraja
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite